Nektar Therapeutics Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount
Nektar Therapeutics (NKTR) reported Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount of $1.27 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-13.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationNondeductibleExpenseOther · last filed 2026-03-13
- Nektar Therapeutics effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2025 was $1.27M.
- Nektar Therapeutics effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2014 was $7.31M, a 6.37% decline from fiscal 2013.
- Nektar Therapeutics effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2013 was $7.81M, a 23.54% increase from fiscal 2012.
- Nektar Therapeutics effective income tax rate reconciliation, nondeductible expense, other, amount for fiscal 2012 was $6.32M.
| Period end | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount 12 month |
|---|---|
| 2025-12-31 | $1.27M 10-K · filed 2026-03-13 |
| 2014-12-31 | $7.31M 10-K · filed 2015-02-26 |
| 2013-12-31 | $7.81M 10-K · filed 2015-02-26 |
| 2012-12-31 | $6.32M 10-K · filed 2015-02-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UroGen Pharma Ltd. (URGN) | $2.015B | -18.42 | |
| PERRIGO Co plc (PRGO) | Ireland | $2.038B | -0.79 |
| Nuvation Bio Inc. (NUVB) | United States | $2.007B | -13.12 |
| Generate Biomedicines, Inc. (GENB) | United States | $2.052B | |
| Biohaven Ltd. (BHVN) | United States | $1.990B | -3.83 |
| AGIOS PHARMACEUTICALS, INC. (AGIO) | United States | $1.962B | -5.38 |
| Trevi Therapeutics, Inc. (TRVI) | United States | $2.091B | -51.93 |
| PALVELLA THERAPEUTICS, INC. (PVLA) | United States | $2.105B | -35.55 |
| Braveheart Bio, Inc. (BRVE) | United States | $2.106B | |
| Sarepta Therapeutics, Inc. (SRPT) | United States | $1.941B | -13.89 |